H. Thorp

The Institute for Defense & Business is a private company based in Chapel Hill, NC. Institute for Defense & Business offers educational programs and research solutions for organizations and individuals. The company's focus is on exploring educational programs and finding solutions for the defense and business industries.

The Saint Louis Symphony Orchestra provides orchestra services. The firm performs musical shows for a live audience and also provides educational programs for music and instruments. The company was founded in 1880 and is headquartered in St. Louis, MO.

Artizan Biosciences, Inc. engages in the provision of healthcare services. It develops curative treatments for inflammatory diseases. The company was founded by Richard A. Flavell, Noah W. Palm and Marcel R. de Zoete and is headquartered in New Haven, CT.

Public Broadcasting Service provides public broadcasting television services. They provide Television programming and related services to 356 noncommercial stations serving all 50 states, Puerto Rico, U.S. Virgin Islands, Guam and American Samoa. It offers oversees program acquisition and provides program distribution and promotion, education services, new media ventures, fundraising support, engineering and technology development and video marketing services. The company was founded in 1969 and is headquartered in Arlington, VA.

Hatteras Venture Partners (Hatteras Venture) is venture capital firm founded in 2000 by Clay B. Thorp and John Crumpler. The firm is headquartered in Durham, North Carolina.

Viamet Pharmaceuticals Corp. engages in the discovery, development, and commercialization of novel pharmaceuticals based on its proprietary metalloenzyme chemistry and biology technology platform. Its clinical portfolio includes novel agents to treat chronic and life threatening fungal infections. Its products include VT-1161, an oral agent that treats onychomycosis; VT-1129, which treats cryptococcal meningitis; and VT-1598, that treats coccidioidomycosis. The company was founded by Herbert Holden Thorp and Thomas V. O'Halloran in December 2011 and is headquartered in Durham, NC.

Viamet Pharmaceuticals, Inc. discovers and develops inhibitors of validated metalloenzymes. The firm's clinical portfolio includes novel agents to treat both chronic and life threatening fungal infections. It also leverage our metalloenzyme expertise in other therapeutic areas including oncology and orphan diseases. The company was founded by Thomas V. O’Halloran and Holden H. Thorp on August 18, 2005 and is headquartered in Durham, NC.